Mylan

Mylan, Theravance win FDA approval for COPD drug
Mylan, Theravance win FDA approval for COPD drug
Biopharma Dive
Theravance
Mylan
Yupelri
COPD
FDA
Flag link:
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Motley Fool
Mylan
earnings
Flag link:
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Coherus
Neulasta
Mylan
biosimilars
Amgen
Flag link:
Early November Brings More Quarterly Reports
Early November Brings More Quarterly Reports
BioSpace
earnings
Akcea
Mylan
Eli Lilly
Regeneron
Flag link:
Momenta starts countdown to biosimilars exit
Momenta starts countdown to biosimilars exit
EP Vantage
Momenta Pharmaceuticals
Mylan
biosimilars
Flag link:
5th Humira biosimilar approved in EU as market entry nears
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Europe
biosimilars
AbbVie
Humira
Mylan
Hulio
Flag link:
FDA extends EpiPen expiration date to ease shortages
FDA extends EpiPen expiration date to ease shortages
Biopharma Dive
Mylan
drug shortages
FDA
EpiPens
Flag link:
Mylan's EpiPen supply woes drag on
Mylan's EpiPen supply woes drag on
Biopharma Dive
Mylan
Pfizer
EpiPens
drug shortages
Flag link:
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
EpiPens
generics
Teva Pharmaceutical
Mylan
allergic reaction
Flag link:
Mylan Launches First Adcirca Generic, Stock Moves Up
Mylan Launches First Adcirca Generic, Stock Moves Up
Market Realist
Mylan
tadalafil
generics
PAH
Adcirca
United Therapeutics
Flag link:
Mylan signs U.S. license deal on Humira with AbbVie
Mylan signs U.S. license deal on Humira with AbbVie
Yahoo/Reuters
AbbVie
Mylan
biosimilars
Humira
Flag link:
Mylan decimates the list price of its Copaxone copy. But why?
Mylan decimates the list price of its Copaxone copy. But why?
Fierce Pharma
Mylan
drug pricing
Copaxone
Flag link:
Mylan launches generic drug-delivery patch for dementia patients
Mylan launches generic drug-delivery patch for dementia patients
Drug Delivery Business News
Mylan
rivastigmine
generics
Novartis
Exelon
dementia
Alzheimer's disease
Parkinson's Disease
Flag link:
Novartis steps in to compete with Mylan’s Epipen
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Adamis Pharmaceuticals
Novartis
Sandoz
Symjepi
Mylan
EpiPens
Flag link:
GSK wins yet another reprieve for blockbuster Advair franchise as Mylan is hit (again) with a CRL
GSK wins yet another reprieve for blockbuster Advair franchise as Mylan is hit (again) with a CRL
Endpoints
Mylan
FDA
Advair
GSK
complete response letter
Flag link:
DoJ investigates Mylan on trade compliance for certain products
DoJ investigates Mylan on trade compliance for certain products
Reuters
DOJ
Mylan
Trade Agreements Act
Flag link:
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
CP Wire
Coherus Biosciences
Neulasta
CHS-1701
Mylan
Biocon
Flag link:
Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate
Coherus Biosciences
Neulasta
CHS-1701
Mylan
Biocon
Flag link:
Generic-Drug Companies to Face First Charges in U.S. Probe
Generic-Drug Companies to Face First Charges in U.S. Probe
Bloomberg
generics
Mylan
Perrigo
Teva Pharmaceutical
price fixing
Flag link:
Mylan cuts workforce at West Virginia plant by 15%
Mylan cuts workforce at West Virginia plant by 15%
Biopharma Dive
Mylan
layoffs
drug manufacturing
Flag link:

Pages